Systemic Prevention and Management for Perioperative Hypothermia and Its Effect on Patients Outcome
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Mar 14, 2019
Trial Information
Current as of June 17, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age≥18 Core temperature preoperation ≥36.0 ℃ and ≤37.5℃ ASA I-III Informed consent
- Exclusion Criteria:
- • emergency operation
- • uncontrolled diebete mellitus with insulin treatment （preoperative blood glucose\>250mg/dL）
- • hyperthyroidism and hypothyroidism
- • Raynaud's disease
- • patients with hematopathy and immune disease
- • anticoagulant and non-steroid anti-inflammatory drug intake with 14 days before operation
- • infectious fever within 4 weeks before operation
- • laboratory abnomality as follow
- • Hemoglobin≤10.0g/L
- • Platelet≤100,000/ml
- • White blood cell\<3000/dl or\>14,000/dl
- • Fibrinogen\<200mg/dL
- • Thrombin time\>40 second
- • International normalized ratio\<70%
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Yuguang Huang, doctor
Study Chair
Peking Union Medcial College Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials